From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.
Nat Commun
; 14(1): 3079, 2023 05 29.
Article
in En
| MEDLINE
| ID: mdl-37248212
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Drug Repositioning
Limits:
Animals
/
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2023
Document type:
Article
Affiliation country:
Francia